Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | KCNA5 | P22460 | 10/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25221022 | 0.84 | ALDH1A1 (0.65) | ALDH1A1KDM4ETSHRKCNA5HTT | |
| SCHEMBL6496563 | 0.79 | ALDH1A1 (0.56) | ALDH1A1KDM4ETSHRKCNA5HTT | |
| SCHEMBL13149677 | 0.78 | ALDH1A1 (0.95) | ALDH1A1KDM4ETSHRKCNA5HTT | |
| SCHEMBL6482607 | 0.77 | ALDH1A1 (0.56) | ALDH1A1KDM4ETSHRKCNA5HTT | |
| SCHEMBL11293119 | 0.77 | GAA (0.85) | ALDH1A1TSHRHTTSMN1; SMN2GAA | |
| SCHEMBL6485781 | 0.76 | KDM4E (0.53) | ALDH1A1KDM4ETSHRKCNA5HTT | |
| SCHEMBL6500436 | 0.76 | KDM4E (0.53) | ALDH1A1KDM4ETSHRKCNA5HTT | |
| SCHEMBL6500035 | 0.76 | KDM4E (0.53) | ALDH1A1KDM4ETSHRKCNA5HTT | |
| SCHEMBL6485461 | 0.76 | KDM4E (0.53) | ALDH1A1KDM4ETSHRKCNA5HTT | |
| SCHEMBL12789840 | 0.74 | HTT (0.68) | ALDH1A1KDM4ETSHRKCNA5HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6861432-B2 | Piperazine derivatives that destabilize androgen receptors | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-03-01 | — | — | US | disclosed |